Archive for Packard Foundation

Abortion groups tell women to lie about abortion pill, claim miscarriage

Posted in Abortion pill, Abortion Pills Illegal, DANCO, Packard Foundation, Self Managed Abortion, self-managed abortion with tags , , , , , , , , , , , , , , , , , , , on June 2, 2019 by saynsumthn

abortion pill

Just as abortion supporters rage over new pro-life laws in Georgia and Alabama, claiming that women could be investigated for miscarriages, comes proof that abortion supporters are actually advising women who experience complications from illegal use of the abortion pill to lie to health care providers and say they had miscarriages.

Currently, abortion insiders, many with ties to abortion pill manufacturer Danco, are pushing for expansion of the abortion pill, despite thousands of adverse effects and two dozen deaths. The abortion pill regimen consists of two drugs: Mifepristone  (or Mifeprex) and Misoprostol. The FDA has warned women against purchasing these dangerous pills online.

Dr. Daniel Grossman, a professor of obstetrics and gynecology at the University of California, San Francisco, who also teaches abortion allegedly told a reporter at The Atlantic that if women using these [self-managed abortion] regimens experience heavy bleeding or some other complication, they are generally advised to go to a hospital and say they had a miscarriage.

Grossman is behind clinical trials to expand the abortion pill for pharmacy dispension and is calling to remove important safety requirements put in place by the FDA, called REMS. This comes as no surprise, as one of the major original investors of abortion pill manufacturer Danco — The Packard Foundation — has funded other Grossman-authored studies. In other words, those behind the studies attempting to do away with FDA safety requirements for the abortion pill stand to gain a significant amount of money if those requirements are removed.

Image: Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )


If you think you might have a complication you should go to a doctor immediately. If you live in a place where abortion is a crime and you don’t have a doctor you trust, you can still access medical care. You do not have to tell the medical staff that you tried to induce an abortion; you can tell them that you had a spontaneous miscarriage. Doctors have the obligation to help in all cases and know how to handle a miscarriage.
The international abortion organization, Women on Web, advises women on its website to present to the ER and claim they are having a miscarriage if they experience complications from the abortion pill in a country where taking the drug is illegal:

The symptoms of a miscarriage and an abortion with pills are exactly the same and the doctor will not be able to see or test for any evidence of an abortion, as long as the pills have completely dissolved. 

Women on Web advises women lie about illegal abortion pill emergencies say miscarriage (accessed 5/14/2019)

According to a report from The Atlantic, Women on Web’s founder, Rebecca Gomperts, launched the site Aid Access to sell the abortion pill online, against FDA requirements. The FDA recently issued Aid Access a warning letter to cease its illegal activity. Last week, over 100 lawmakers sent a letter to the FDA, asking it to continue to monitor and crack down on dangerous websites like Aid Access.

But that has not stopped other proponents of self-managed abortion, who seem set on placing women in harm’s way. The website Plan C, founded in 2015 by Francine Coeytaux and Elisa Wells, tells women, “Those who choose to self-manage their abortion have no obligation to report that they have used misoprostol and there is no way it can be detected in the body, even if a blood test is taken. Scientists have found that there is no noticeable difference between a naturally occurring miscarriage and the bleeding that happens after taking misoprostol.”

Plan C Website FAQ where get

Then, if something goes wrong (and it most likely will), the Plan C website, which is under the fiscal sponsorship of the National Women’s Health Network, advises women to present to the emergency room or other health care offices and simply claim they are experiencing a miscarriage.

PlanC website tells women aborting to present with Miscarriage, accessed 5/14/2019

Live Action News previously reported how abortion organization, Reproaction, purchased over $4,000 in ads to promote a push for self-managed abortion — something unapproved by the FDA. Reproaction also advises women to seek care by lying about their abortions.

A webinar published in 2018 states in part that women “need information to reduce the risk of arrest… what the signs of a complication are and most importantly what to say if one needs to go to the doctor…. [T]he symptoms of an abortion with pills and miscarriage are exactly the same and the treatment for any kind of complication is exactly the same…. It’s important for people to understand there’s no test for these pills in blood or urine so if they present with a miscarriage they can get the healthcare that they need….”

tweet from “Helen Bolton” — whose profile implies that he or she is with organized abortion groups “ and ” — reiterates the deception being proposed: “Misoprostol is basically OTC in a lot of the world and is regularly used to self-manage abortions in places where it’s illegal. Even with complications, the patient looks like they had a miscarriage, so people can go to a hospital (provided miscarriages aren’t investigated).”

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

Others have made similar suggestions.

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

FDA warns women: “Do Not Buy Mifeprex Over the Internet.

FDA warns consumers to not buy abortion pills over the internet

The FDA adds, “You should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your health (and the health of others). Mifeprex has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.”

According to the FDA’s adverse effects reports through 2018, there have been reports of 24 deaths associated with Mifeprex since the product was approved in September 2000, as well as 4,200 reported adverse effects, including hospitalization and other serious complications.

  • This article is reprinted with permission. The original appeared here at Live Action News.

Taxpayers send millions to abortion training program at UCSF

Posted in Abortion Pill Connections, Abortion Pill Study, Abortionist, Abortionist Training, Bill Gates, Fellowship in Family Planning (FFP), Hewlett Foundation, Innovating Education in Reproductive Health, National Abortion Federation, Packard Foundation, Philip Darney, Ryan Residency, Uta Landy with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

Who’s paying millions for this abortion training program? Taxpayers.

third trimester abortion, abortion training

Abortion training is being orchestrated out of a University of California, San Francisco (UCSF) program which receives millions in government dollars. UCSF trains abortion providers through their Bixby Center for Global Reproductive Health , which claims to be “one of the few research institutions to unflinchingly address abortion, investigating multidimensional aspects of abortion care in the United States and globally.” Bixby claims their work has:

According to Bixby’s annual reports, in 2014, nearly $22 million dollars (52 percent) of Bixby’s revenue came from the taxpayer, although the report does not specify whether the funds were state or federal. By 2015, although Government dollars made up only 18 percent of Bixby’s revenue, it totaled over $18 million in taxpayer dollars. Bixby is conveniently located in California, which permits millions in taxpayer dollars to fund abortions and has no requirement that abortion numbers be reported to the Centers for Disease Control (CDC) for data analysis.

UCSF Bixby Gov Funding 18 million in 2015 to 2016 AR

Taxpayer dollars sent to UCSF for fetal research include millions from the National Institutes of Health (NIH). A recent report published by CNS News breaks down the dollars of the multi-year contract:

[T]he Department of Health and Human Services has granted contracts to UCSF to make “humanized mice.”… According to contract information published on the Federal Procurement Data System, the new three-month extension will pay UCSF $521,082—bringing the total payments the federal government has made to UCSF for this contract to $10,596,960. If the government continues renewing the contract through Dec. 5, 2020, HHS would end up paying UCSF a total of $13,799,501.

In addition to government (taxpayer) dollars, Bixby receives funding from a number of organizations collaborating to expand abortion, such as:

UCSG Bixby trains abortion to increase access (Image: Twitter)

According to Bixby, which was created to address a shortage of abortionists dating back to the mid 1980’s, the number of US abortion providers decreased by 38% between 1982 and 2005, and some 87% of US counties do not have an abortion provider.

Bixby runs two flagship programs, which “provide the opportunity to develop high-level research and clinical skills in abortion and contraception:”

FFP was established by Dr. Philip Darney, and as previously reported, FFP’s website makes it clear that abortion is their mission, stating that the family planning fellowship is a “two-year fellowship focused on subspecialist training in research, teaching and clinical practice in abortion and contraception… and they play an active role in discussions in the media related to family planning access and advocate for their patients in popular media outlets.”

Fellowship in Family Planning FFP FB Page (Image credit: Facebook)

Live Action News also previously reported how the Kenneth J. Ryan Residency Training Program in Abortion and Family Planning was founded in 1999 by Dr. Uta Landy, a former director of the National Abortion Federation and a recipient of Planned Parenthood Federation of America’s infamous Margaret Sanger Award. According to the Bixby Center, Landy established “one of the first abortion clinics in New York after legalization in 1970, and became the first executive director of the National Abortion Federation in 1979.” Landy was recently caught in undercover footage from the Center for Medical Progress talking about late-term abortions.

Philip Darney and Uta Landy at UCSF abortion training

The Ryan program is now at 70 major medical schools in the US and Canada, according to their website.

The Bixby Center was originally founded as the Center for Reproductive Health Research & Policy in 1999 by Philip Darney, MD and Nancy Padian, who were shortly thereafter joined by Claire Brindis, DrPH, MPH, and Felicia Stewart, MD, according to their report. The Center offers online abortion training courses and lectures through its Innovating Education in Reproductive Health which is described as “a digital hub that highlights innovative family planning and abortion curricula, tools, teaching techniques and research from educational leaders around the world.”

Innovating Education at UCSF abortion training

The group’s week by week abortion course, “Abortion Quality Care and Public Health Implications,” has a stated goal to destigmitize abortion, among other things. The “career planning brochure” instructs graduates to “moonlight” at abortion facilities and to “highlight [their] abortion training as a special skill set” when they apply to a practice.

Innovating Education Abortion Career Planning Brochure

The abortion training course is introduced by Jody Steinauer, Associate Professor at UCSF. The course is “directed at health care students and professionals.”

The video lectures lead up to the topic of  “abortion after the first trimester,” in week four, where Steinauer admits that later abortions “can be a difficult topic to discuss for many due to feelings about a more developed fetus.”

Jody Steinauer at UCSF abortion training

Despite the abortion industry’s frequent denial of facts about fetal development, Bixby’s TEACH Program (Training Early Abortion for Comprehensive Healthcare) workbook acknowledges that the fetal heartbeat can be detected very early, around six weeks gestation (dates used are gestational, which is measured at two weeks more than the date of fertilization):

The embryo follows a predictable path of development and therefore can be used to date a pregnancy based on its size. The embryo appears at approximately 6 weeks and grows 1 mm per day thereafter until 12-14 weeks. After 12 weeks, fetal flexion and extension make measuring length more challenging and using the fetal biparietal diameter (BPD) is preferred. Cardiac activity appears around 6 ½ weeks.

Bixby abortion training workbook TEACH

The workbook then gives suggestions on how to speak to an abortion patient about the baby. But because this is about ending the life of a developing human person in the womb, the workbook suggests abortion providers use euphemisms like “pregnancy” instead of scientifically correct terminology such as fetus or baby.

“Your pregnancy is 8 weeks along,” instead of  “Your baby is 8 weeks old.”

Bixby abortion training workbook TEACH communication

In upcoming Live Action News articles, we will highlight various teaching lectures published by the UCSF abortion training program.

    • This article is reprinted with permission. The original appeared here at Live Action News.

FDA: 24 women die from abortion pill, thousands of serious complications

Posted in AAPLOG, Abortion death, Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, DANCO, Daniel Grossman, Generic Abortion Pill, Inc., Packard Foundation with tags , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

As more women die from abortion pill, the FDA approves a generic version

abortion pill, emergency contraception

 

The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and the abortion industry is pushing for the dangerous abortion inducing chemicals to be dispensed online or by mail. According to a notice from the FDA, the generic version is approved for use as an abortifacient. This news comes just a day before the FDA updated its adverse effects reports through 2018, stating, “As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal…” The FDA’s 2017 report put the number of deaths at 22.

This means that in 2018 alone, two more women died from taking the abortion pill. And yet, now a generic version is going to be made available.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications.

On April 11, 2019, the FDA approved GenBioPro, Inc.’s abbreviated new drug application for a generic Mifeprex, which, when used with Misoprostol is approved as an abortion pill regimen. The FDA states (emphasis added), “This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex and can be safely substituted for Mifeprex. Like Mifeprex, the approved generic product is indicated for the medical termination of intrauterine pregnancy through 70 days gestation….”

READ: The secrecy surrounding the abortion pill’s maker and influential financial investors must end

Generic abortion pill by GenBioPro approved by FDA

The FDA also states clearly that although they modified the Mifeprex application to include “mifepristone products,” this change in no way removes the FDA’s REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Of note, on April 11, 2019, FDA approved a supplemental application for Mifeprex, approving modifications to the existing approved REMS for Mifeprex to establish a single, shared system REMS for mifepristone products (including Mifeprex as well as the approved generic version of Mifeprex) for the medical termination of intrauterine pregnancy through 70 days gestation. In establishing the single, shared system REMS, no changes were made to the substantive elements of the REMS. This single, shared system REMS is known as the Mifepristone REMS Program.

Find approval information for this 2019 supplement here.

The approved generic version of Mifeprex generally has the same labeling as Mifeprex…Under the law, the approved generic version of Mifeprex is required to use a single, shared system REMS with the brand product, Mifeprex. This single, shared system REMS, known as the Mifepristone REMS Program, sets forth the distribution requirements that must be followed for both Mifeprex and the approved generic version of Mifeprex.

Requiring that the generic be subject to FDA’s REMS is good news for now, because, as Live Action News has previously reported, the abortion lobby is attempting to expand access to the abortion pills via mail order or pharmacy by pushing “self-managed abortion,” described by Guttmacher as ending a pregnancy “without direct supervision by a health care provider.” To accomplish this, REMS, must be eliminated.

READ: What you should know about the dangerous ‘self-managed’ abortion pill push

Dr. Donna Harrison, Executive Director American Association of Pro-Life Obstetricians and Gynecologists(AAPLOG), agreed, telling Live Action News (emphasis added):

Allowing a generic equivalent of Mifeprex basically means that the patent restrictions have run out. So, new drugs have a patent which is time limited… and in the case of Mifeprex, the patent was held by the Population Council. So, now that the patent has run out, generics are allowed. But this does not change the restrictions. REMS are still in place until FDA changes the restrictions. So, just to clarify, this does not mean that Mifeprex is OTC [over-the-counter]. It just changes how much quality control goes in to the pill manufacturing process and how much Danco can charge for the drug.

The move towards a generic drug is being hailed a victory by abortion advocates, specifically Dr. Daniel Grossman, who has deep tiesto the “self-managed” abortion pill push.

Image: FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

Image: FDA Approves generic abortion drug NWHC (Image: Twitter)

FDA Approves generic abortion drug NWHC (Image: Twitter)

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The original drug (Mifeprex) was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council, and was seeded by the Packard Foundation among other pro-abortion philanthropy groups. They then set up a highly secretive company named Danco to manufacturer the drug.

The generic version is produced by GenBioPro, Inc., which also appears to have the financial support of abortion collaborators. In fact, Packard gave GenBioPro, Inc. $185,000 in 2016 and 100,000 in 2017. According to the Nevada Secretary of State, a 2007 filing for the company was permanently revoked. A new filing in 2011 is active and shows a registered agent of CSC Services of Nevada, Inc. and the only officer listed is E. Masingill.

The FDA warns consumers they should not buy Mifeprex or GenBioPro, Inc.’s approved generic version of Mifeprex, Mifepristone Tablets, 200 mg., over the Internet because they will bypass important safeguards designed to protect patient health.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Media ignores profit motive of researcher attempting to discredit abortion pill reversal

Posted in Abortion pill, Abortion Pill Connections, Abortion Pill Study, Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Clinical Trial APR, Contraception Journal, DANCO, Daniel Grossman, Mitchell D. Creinin, Population Council, Reproductive Health Professionals (ARHP), RU-486, University o California San Francisco (UCSF), University of California, University of California Davis with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

abortion pill birth control

 

The principal investigator of a study seeking to disprove the legitimacy of abortion pill reversal has direct ties — including financial ties — to abortion pill manufacturer Danco, which was formed by the eugenics-founded Population Council. This potential conflict of interest should demand scrutiny from the media — but instead, the media willingly questions abortion pill reversal based upon a single “expert” that receives compensation from Danco. This “expert” is Mitchell D. Creinin, a professor at University of California, Davis, sponsor of the study.

Mitchell Creinin has long history with abortion. He is an abortionist who was involved in clinical trials of RU-486 at Magee-Women’s Hospital Dept. of OB/GYN Pittsburgh, PA. He was the previous medical and lab director of Planned Parenthood of Western Pennsylvania, as described by Oxford University Press. He worked on an abortion training publication for the National Abortion Federation (NAF). He has served on the Board of Directors for the Association for Reproductive Health Professionals (ARHP). He is also listed among the advisory counsel for the early abortion training guide published by Advancing New Standards in Reproductive Health (ANSIRH), part of UCSF’s Bixby Center for Global Reproductive Health.

As I detailed in a Twitter thread shown below, Creinin’s abortion history and connections to the abortion pill’s manufacturer are deep and worth mentioning. This calls into question the validity of his study into abortion pill reversal. Creinin has financial incentive to make sure the abortion pill remains in demand, as do the study’s sponsors. This is a blatant conflict of interest.

Carole Novielli@CaroleNovielli

Person behind “Clinical Trial” to attempt to disprove abortion pill reversal (APR) – connected to abortion and takes money from abortion pill manufacturer- can you say CONFLICT? https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/ 

The who’s who (and who not to trust) behind an abortion pill reversal study

Abortion advocates want broad access to the abortion pill, and are pushing studies funded by people who stand to gain financially from abortion pill sales.

liveaction.org

See Carole Novielli’s other Tweets

 

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

3/ Mitchell D Creinin is Professor at University of California, Davis (UCD) – the anti-APR study’s sponsor more here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/ceovZv7Uqr

See Carole Novielli’s other Tweets
View image on Twitter

Carole Novielli@CaroleNovielli

4/ Mitchell D Creinin is a consultant for abortion pill manufacturer, receiving consulting fees $$/ honorarium f/ DANCO https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/GZ4s3kfmSp

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

5/ Mitchell D Creinin provided “third-party telephone consults,” for pill (Mifeprex or RU486) DANCO – formed by Population Council
More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/MsAH2mXW7v

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

6/ Creinin founding member of Society of Family Planning (SFP) began w/ Packard Foundation $$ – which is funding abortion pill studies/ publications. SFP funding study- granted UC Davis $401,764. https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/FTtWWM90gm

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

7/ Creinin, deputy editor SFP’s journal Contraception, publishes Packard-funded reports promoting self-managed abortion. Funds Gynuity which sponsors abortion pill expansion studies https://www.liveaction.org/news/exposed-conflicts-interest-abortion-pill/  more here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/CarYNczMXg

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

8/ Packard’s investment seeded abortion pill MFG, DANCO including a $14 million loan as early as 1996 to bring drug RU486 (Mifepristone) to US Packard funds UC Davis sponsor of study https://www.liveaction.org/news/secrecy-abortion-pill-maker-investors/  More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/  pic.twitter.com/SYzUaTfwHV

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

9/ Creinin is Principal Investigator (PI) in another clinical trial by abortionist on pharmacy dispension of abortion pill https://www.liveaction.org/news/this-abortionist-claims-abortion-pill-doesnt-need-regulations-hes-wrong/ 
More here https://www.liveaction.org/news/whos-who-abortion-pill-reversal-study/ 

The who’s who (and who not to trust) behind an abortion pill reversal study

Abortion advocates want broad access to the abortion pill, and are pushing studies funded by people who stand to gain financially from abortion pill sales.

liveaction.org

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

10/ Creinin previous medical/lab director Planned Parenthood of Western Pennsylvania – and an abortionist involved in original clinical trials of RU-486 abortion pill

See Carole Novielli’s other Tweets

Carole Novielli@CaroleNovielli

11/ In summary- FOLLOW THE MONEY – something this @VICE report FAILED to do – https://news.vice.com/en_us/article/j5wqqp/theres-no-proof-abortion-reversals-are-real-this-study-could-end-the-debate 
These abortion “studies” are tied together by $$ from / Danco support from

There’s no proof “abortion reversals” are real. This study could end the debate.

Four states already mandate that doctors advise women their abortions can be reversed.

news.vice.com

See Carole Novielli’s other Tweets

As shown in the Twitter thread above, Creinin serves as consultant for abortion pill (Mifeprex) manufacturer, Danco, and receives consulting fees and compensation from the company. In addition, he receives honorarium from Danco. Creinin also provides “third-party telephone consults” for Danco. Creinin’s study sponsor is financed by the Packard Foundation, one of Danco’s major financial investors.

If this all weren’t enough to show a major conflict of interest, Creinin is also a founding member of the Society of Family Planning, which is collaborating on the study. This organization’s mission is to support abortion research, it, too, is funded by the Packard Foundation. Creinin is also the deputy editor of SFP’s official journalContraceptionPackard-funded studies in this journal unsurprisingly support the pro-abortion cause, claiming self-managed abortion is safe, and urging the undoing of current FDA safety standards restricting dispensation of the abortion pill (known as REMS). The Journal’s editorial board has been stacked with abortion industry insiders, including a National Abortion Federation board member and members of the Population Council (responsible for bringing the abortion pill into the US and forming DANCO, the manufacturer of the pill).  Obviously, the journal is pro-abortion.

Creinin is also the principal investigator in another clinical trial run abortionist/researcher Daniel Grossman (professor at University of California, San Francisco) on pharmacy dispension of the abortion pill.

Despite the fact that this conflict exists between the study’s “investigator” and Danco, media outlets ignore it. Such was the case over at Vice, which published the latest attack against abortion pill reversal, highlighting Creinin’s study without drawing one line to his connections to the abortion pill’s manufacturer. Vice headlined their hit piece: “THERE’S NO PROOF ‘ABORTION REVERSALS’ ARE REAL. THIS STUDY COULD END THE DEBATE,” in spite of the fact that Creinin’s study is only at the recruiting stage, and hasn’t reached any conclusions yet.

Or has it?

Creinin makes no secret that he doesn’t believe in abortion pill reversal  — and his profitable relationship with Danco should give any critically thinking person reason to question the motivations behind this push to “test” the effectiveness of the abortion pill reversal protocol.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Conflicts of interest? Abortion pill investor funds study claiming women want expanded distribution

Posted in Abortion pill, DANCO, David and Lucile Packard Foundation, George Soros, Journal Contraception, Population Council, RU-486, self-managed abortion, Warren Buffet with tags , , , , , , , , , , , , , , , , , , , , , on November 30, 2018 by saynsumthn

EXPOSED: Massive conflicts of interest found in new abortion pill study

abortion pill

Abortion industry insiders insist that there is a large public interest in expanding distribution of the abortion pill by lifting safety requirements for the drug regimen. Now, right on cue, a study done by abortion industry insiders and funded by a large investor of the abortion pill’s manufacturer purports to show that women want “alternative models” for obtaining the abortion pill. But the move is anything but organic and is being strategically driven by abortion industry insiders.

Published by the Journal Contraception, the study claims that women support obtaining abortion pills “(1) in advance from a doctor for future use, (2) over-the-counter (OTC) from a drugstore and (3) online without a prescription.” But there is more beneath the surface at play here. Not only are the Journal and its authors deeply embedded in the abortion industry, but the funding for this study also came from the David and Lucile Packard Foundation, a major investor in Danco, the manufacturer of the abortion pill.

In 1998, according to reports, Packard seeded Danco with $10 million, and Packard also currently funds Gynuity Health Projects, which conducts abortion pill clinical trials. Packard’s investment in Danco included a $14 million loan as early as 1996 to bring the drug to the US, as well as additional grants made in 2000, 2004, and 2009. And yet, the Journal claims there are no conflicts of interest.

Image: Packard Foundation self managed abortion pill study (Image: 2018 study from Journal Contraception)

Packard Foundation self managed abortion pill study (Image: 2018 study from Journal Contraception

Additional investors in Danco include George Soros (Open Society), Warren Buffet (Buffet Foundation) and the California-based Kaiser Family Foundation.

Image: Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Journal Contraception  

Authors

Image: Journal Contraception 2018 study on self managed abortion

Journal Contraception 2018 study on self managed abortion

 

Image: Author Sarah Raifman Tweet June 2018 SB320 (Image: Twitter)

Author Sarah Raifman Tweet June 2018 SB320 (Image: Twitter)

  • Author Diana G. Foster is another ANSIRH staffer who opposes late-term abortion restrictions. She sits on the board of the Later Abortion Initiative (LAI), a group with the mission of “increas[ing] the number of sites where later abortion is available” and “expand[ing] the number of physicians who can perform later abortion, especially at 20 weeks’ gestation and beyond.” Foster has been applauded by the abortion advocacy group, NARAL.
Image: Author Diana G Foster applauded by NARAL 2016 tweet

Author Diana G Foster applauded by NARAL 2016 tweet

READ: Amazing: Over 500 babies saved thanks to abortion pill reversal

The abortion pill regimen, RU486, is made up of two drugs: Misoprostol and Mifeprex. This regimen is currently regulated by the FDA under a system known as REMS. As Live Action News previously explained, taking the abortion pill regimen isn’t just a simple thing — if a woman is too far along or if her pregnancy is ectopic, these factors put women at additional risk. There have been 22 reported deaths and thousands of hospitalizations since the abortion pill’s approval in 2000.

Live Action News has previously documented how:

  • Abortion insiders brought RU486 to the US.
  • Abortion insiders are conducting clinical trials for “home-use” and “self managed” abortions.
  • Abortion insiders collaborated to push “home use” abortions.
  • Abortion insiders recently coordinated a Tweetfest to promote “self-managed” abortions.
  • And now, abortion insiders conveniently roll out a study claiming women support “alternative models of medication abortion provision.”

Despite the clear conflicts of interest surrounding this study about the abortion pill, it and other studies like it are likely to go unchallenged by the mainstream media, just as abortion industry leader Planned Parenthood’s claims continue to go unchallenged. This does a grave disservice to women.

Former Planned Parenthood Golden Gate employees describe longstanding pattern of financial mismanagement, by CEO

Posted in Abortion, Planned Parenthood with tags , , , , , , , , , , , , on August 12, 2010 by saynsumthn


Planned Parenthood Golden Gate’s former employees blame the organization’s longstanding pattern of financial mismanagement, former PPGG CEO, Dian Harrison. Because of this, the national Planned Parenthood organization has announced it will divorce itself from the networks of clinics that serve patients in five Bay Area counties, citing fiscal and administrative problems with the local organization. Effective Sept. 3, Planned Parenthood Golden Gate must operate under another name, a representative of the national organization said that Planned Parenthood Golden Gate had failed to uphold the “standards and guidelines” by which each separately incorporated affiliate must abide, but that the details of the situation were confidential.

“They were not meeting our standards for administrative and fiscal management,” said Karen Ruffato, vice president of affiliate services for the national organization.

According to a press release issued by, “Life, Liberty and the Pursuit of Happiness” a film financed by Planned Parenthood Golden Gate,Dian Harrison also served on these boards:the National Abortion Federation, the American Civil Liberties Union (ACLU), the National Association for the Advancement of Colored People (NAACP), and she blogs for RH Reality Check , Harrison was also a guest speaker at a NAF conference

In 2008 Assembly member Mary Hayashi Named Dian Harrison Of Planned Parenthood Golden Gate Her “Woman Of The Year”

In a report of the top paid Planned Parenthood employees for 2008, Harrison made the list when the California Catholic Daily reported this

Dian Harrison, President and Chief Executive Officer
Salary: $274,438
Benefits: $18,976
Expense Account: $11,340
Total Compensation: $304,754

Here Harrison brags about her rich and lavish new design for the abortion clinic she managed !

A report in the Bay Citizen:

The most recent tax documents filed with the I.R.S. suggest that PPGG has not only been losing money in recent years, but is in financial disarray. For the tax year ending June 30, 2009, it showed a loss of $2.8 million.

Yet, from financial information for the previous year, it’s unclear just how much money the organization lost because it filed three separate sets of numbers with the I.R.S. In the filings, losses ranged between nearly $1.9 and $2.8 million. Two different accounting firms signed off on the various filings.

Executives for PPGG did not return numerous calls or respond to e-mails seeking comment for this story.

Tax documents also show that the organization’s financial problems did not start with the catastrophic recession and California’s fiscal crisis, which has delayed MediCal reimbursements from the state. Tax documents for the year ending June 30, 2007 show that the organization lost $181,000 that year.

Yet, the organization’s fiscal problems date farther back. Documents associated with a 2004 accreditation review of Planned Parenthood Golden Gate show that the local affiliate did not meet the national federation’s financial standards for its affiliates. Of nine indicators of financial health, Planned Parenthood Golden Gate was given a “not met” rating for five of them. For instance, the affiliate had only 11.4 days of cash on hand, as opposed to the required 60 days.

Planned Parenthood Federation of America executives refused to comment on the accreditation documents on the grounds that they’re internal and confidential.
On Wednesday, the charitable trusts division of the state’s attorney general’s office sent a warning letter to the Planned Parenthood Golden Gate Action Fund, the political advocacy and public policy arm of the affiliate, because the organization has failed to file copies of its tax documents with that that office for at least 10 years.
“We do not have any reports on file for them,” Rebecca MacLaren from the attorney general’s press office wrote in an e-mail.

The warning cautioned that if the organization fails to file those forms within 30 days, its registration would be suspended and officers would be personally liable for late fees.

In the letter, the clinicians detail a myriad of problems in the organization, including their concerns about “the misappropriation and mismanagement of PPGG’s funds.” The letter accuses the executive staff of profligate spending during lean times:

It is apparent that while Medical Services has been mandated and has complied with financial reform and cost savings, the Executive Administrative members have failed to adhere to their own mandate for financial restrictions. Executive staff’s personal expenditures are excessive and are not aligned with the mandatory fiscal restrictions. Flagrant use of PPGG funds to pay for personal belongings, personal services and exorbitant technology products is seemingly unchallenged and not subject to the same financial scrutiny that clinic supplies and staff salaries are, for example.

When Harrison replied to their concerns in a letter dated November 14, 2008, she assured the clinicians and doctors that administration was feeling the fiscal pain, too: “Administration has temporarily or permanently frozen a number of positions, budgets were cut, expenses were halted for a period of time and office supplies were not purchased,” she wrote.

And from the San Francisco Bay Guardian:

Former employees saw problems coming at Planned Parenthood Golden Gate
By Rebecca / San Francisco Bay Guardian
Created 08/11/2010 – 4:08pm

This week’s announcement that Planned Parenthood Federation of America (PPFA) was severing ties with Planned Parenthood Golden Gate (PPGG) came as no surprise to some former employees, who have for months been trying to sound the alarm that the chapter was being mismanaged, had major financial problems, and was in a steep decline that could threaten important reproductive care services that low-income women rely on.

A former PPGG employee with knowledge of the organization’s internal affairs described a longstanding pattern of financial mismanagement when former president and CEO Dian Harrison was at the helm. There was widespread concern about spending on expensive marketing campaigns and lavish functions, the person said, and a high level of employee turnover and discontent.

Warning signs of financial difficulties surfaced at least a year ago. Dan Cohen, a spokesperson of the Packard Foundation — a major donor to PPGG — told the Guardian that Packard awarded PPGG a 12-month, $30,000 “organizational effectiveness” grant, which will expire in September. The grant “allows an organization to select a talented, external provider to help them think through some of these challenges,” Cohen explained. The Packard Foundation also awarded a 3-year grant for general operating support for $800,000, which will also expire next month.

Another former employee told the Guardian that she would love to discuss internal problems, but was made to sign a confidentiality agreement upon leaving the organization.

Therese Wilson, executive vice president of Planned Parenthood Golden Gate — who took over PPGG when Harrison left last year on medical leave — did not return repeated calls seeking comment.

An internal PPGG document provided to the Guardian displays the agency’s on-hand cash reserves as compared with other affiliates, suggesting that the reserve ratios were at or below the minimum required by the national Planned Parenthood federation for all but one year from 1998 to 2007 — and well below that of other affiliates of similar size. That is a key requirement for meeting accreditation standards.

When we asked Elizabeth Toledo, a PPFA representative, about this apparent pattern she said she could not comment because she had not seen the documents. She also said the accreditation reviews were confidential. “Understanding the true financial picture for health care providers takes a very in-depth evaluation,” Toledo said. “PPFA and PPGG were working together over the last few years to resolve fiscal challenges.”

Despite delays at the state level in awarding nonprofit funding and the loss of support from the national organization, Toledo and a union representative for PPGG employees both said they believe the clinics will continue serving patients under a different name.

“They plan to stay open, and employees are planning to stay,” said SEIU Local 1021 representative Sarah Sherpun-Zimmer, who has been a union rep for PPGG employees for the last two years. “Folks are really happy working there and they feel like it’s going in a good direction.”

PPGG operated eight clinics, which will lose their Planned Parenthood accreditation Sept. 3, effectively severing their ties to a trusted entity that thousands of low-income women rely upon for birth control, abortion procedures, and other forms of reproductive health care. PPGG operates clinics in San Francisco, Alameda, San Mateo, Sonoma, Marin, and Mendocino counties, serving about 55,000 women per year.

Roughly 92 percent of the clients they serve live at or below the federal poverty line, according to PPGG’s 2008 annual report.

Planned Parenthood affiliates Mar Monte and Shasta Diablo are in the process of hatching plans for taking over some of the eight affected clinics or otherwise growing their own operations to cover any gaps in service area, according to Toledo. She said neighboring affiliates are in a position financially to be able to cover a wider territory and added that they have been in “expansion mode,” adding new clinics over the past couple years.

“It’s unusual to have a disaffiliation,” she said. “But it’s not unusual for national committees to have a reallocation of service area. That part is well-practiced.” Toledo added that “Every effort possible will be made” to ensure continuity of care.
_____________________________________________________________________________________________________________________________________

The National Planned Parenthood Office has NEVER denounced their racist founder Margaret Sanger who pushed eugenics, sterilization, and black genocide as documented in the film: Maafa21